The Oncosearch | Oncotarget

Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia Research Paper

Bianca Schaefer, Soenke Behrends

Published Jun 27, 2017 · Vol. 8, No. 40 · pp. 67406-67421

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Stefania Napolitano, Giulia Martini, Erika Martinelli, Valentina Belli, Alessia Parascandolo, Mikko O. Laukkanen, Vincenzo Sforza, Floriana Morgillo, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani

Published Jun 27, 2017 · Vol. 8, No. 40 · pp. 67592-67604

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Jingwei Shao, Guirong Zheng, Hongning Chen, Jian Liu, Aixiao Xu, Fan Chen, Tao Li, Yusheng Lu, Jianguo Xu, Ning Zheng, Lee Jia

Published Jun 27, 2017 · Vol. 8, No. 45 · pp. 78351-78364

Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity Research Paper

Huan Liu, Le Li, Hua Chen, Rui Kong, Shangha Pan, Jisheng Hu, Yongwei Wang, Yilong Li, Bei Sun

Published Jun 27, 2017 · Vol. 8, No. 37 · pp. 61674-61686

Advanced alveolar soft part sarcoma responds to apatinib Case Report

Yong Zhou, Fan Tang, Yiying Wang, Li Min, Yi Luo, Wenli Zhang, Rui Shi, Hong Duan, Chongqi Tu

Published Jun 22, 2017 · Vol. 8, No. 30 · pp. 50314-50322

Structural basis of mutant-selectivity and drug-resistance related to CO-1686 Research Paper

Xiao-E Yan, Su-Jie Zhu, Ling Liang, Peng Zhao, Hwan Geun Choi, Cai-Hong Yun

Published Jun 21, 2017 · Vol. 8, No. 32 · pp. 53508-53517

TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis Research Paper

Fengyuan Che, Jiawei Yin, Yanchun Quan, Xiaoli Xie, Xueyuan Heng, Yifeng Du, Lijuan Wang

Published Jun 21, 2017 · Vol. 8, No. 32 · pp. 53495-53507

T315I⁺ tyrosine-kinase independent CML cells resistance News

Franck Emmanuel Nicolini, Elodie Grockowiak, VÃ©ronique Maguer-Satta

Published Jun 19, 2017 · Vol. 8, No. 27 · pp. 43600-43601

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase Research Paper

Salvatore Nicola Bertuccio, Salvatore Serravalle, Annalisa Astolfi, Annalisa Lonetti, Valentina Indio, Anna Leszl, Andrea Pession, Fraia Melchionda

Published Jun 19, 2017 · Vol. 8, No. 66 · pp. 109915-109923

Exosomes in diagnosis and therapy of prostate cancer Review

Jun Pan, Meng Ding, Kai Xu, Chunhua Yang, Li-Jun Mao

Published Jun 17, 2017 · Vol. 8, No. 57 · pp. 97693-97700

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma Review

Hilary R. Keller, Xin Zhang, Li Li, Helmut Schaider, James W. Wells

Published Jun 16, 2017 · Vol. 8, No. 43 · pp. 75675-75686

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

Vihren N. Kolev, Winnie F. Tam, Quentin G. Wright, Sean P. McDermott, Christian M. Vidal, Irina M. Shapiro, Qunli Xu, Max S. Wicha, Jonathan A. Pachter, David T. Weaver

Published Jun 16, 2017 · Vol. 8, No. 31 · pp. 51733-51747

Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells Research Paper

Bo Li, Xinzhe Li, Haojun Xiong, Peng Zhou, Zhenhong Ni, Teng Yang, Yan Zhang, Yijun Zeng, Jintao He, Fan Yang, Nan Zhang, Yuting Wang, Yingru Zheng, Fengtian He

Published Jun 16, 2017 · Vol. 8, No. 31 · pp. 51748-51757

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum Priority Research Paper

Danielle M. Greenawalt, Winnie S. Liang, Sakina Saif, Justin Johnson, Petar Todorov, Austin Dulak, Daniel Enriquez, Rebecca Halperin, Ambar Ahmed, Vladislav Saveliev, John Carpten, David Craig, J. Carl Barrett, Brian Dougherty, Michael Zinda, Stephen Fawell, Jonathan R. Dry, Kate Byth

Published Jun 15, 2017 · Vol. 8, No. 59 · pp. 99237-99244

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients Research Paper

Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Aiko Sueta, Keiichi Murakami, Yoko Omoto, Hirotaka Iwase

Published Jun 14, 2017 · Vol. 8, No. 32 · pp. 52142-52155

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer Review

Jose Mauricio Mota, Katharine Ann Collier, Ricardo Lima Barros Costa, Timothy Taxter, Aparna Kalyan, Caio A. Leite, Young Kwang Chae, Francis J. Giles, Benedito A. Carneiro

Published Jun 13, 2017 · Vol. 8, No. 51 · pp. 89284-89306

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Jinyou Liu, Suryavathi Viswanadhapalli, Lauren Garcia, Mei Zhou, Binoj C. Nair, Edward Kost, Rajeshwar Rao Tekmal, Rong Li, Manjeet K. Rao, Tyler Curiel, Ratna K. Vadlamudi, Gangadhara R. Sareddy

Published Jun 12, 2017 · Vol. 8, No. 30 · pp. 50002-50014

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy Research Paper

Ernestina Marianna De Francesco, Marcello Maggiolini, Herbert B. Tanowitz, Federica Sotgia, Michael P. Lisanti

Published Jun 12, 2017 · Vol. 8, No. 34 · pp. 56126-56142

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells Priority Research Paper

Paul E. Clavijo, Ellen C. Moore, Jianhong Chen, Ruth J. Davis, Jay Friedman, Young Kim, Carter Van Waes, Zhong Chen, Clint T. Allen

Published Jun 11, 2017 · Vol. 8, No. 34 · pp. 55804-55820

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma Research Paper

Qing-Yun Chong, Ming-Liang You, Vijay Pandey, Arindam Banerjee, Yi-Jun Chen, Han-Ming Poh, Mengyi Zhang, Lan Ma, Tao Zhu, Salundi Basappa, Liang Liu, Peter E. Lobie

Published Jun 9, 2017 · Vol. 8, No. 43 · pp. 74188-74208

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia Research Paper

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity Research Paper

Advanced alveolar soft part sarcoma responds to apatinib Case Report

Structural basis of mutant-selectivity and drug-resistance related to CO-1686 Research Paper

TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis Research Paper

T315I⁺ tyrosine-kinase independent CML cells resistance News

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase Research Paper

Exosomes in diagnosis and therapy of prostate cancer Review

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma Review

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells Research Paper

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum Priority Research Paper

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients Research Paper

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer Review

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy Research Paper

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells Priority Research Paper

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia Research Paper

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity Research Paper

Advanced alveolar soft part sarcoma responds to apatinib Case Report

Structural basis of mutant-selectivity and drug-resistance related to CO-1686 Research Paper

TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis Research Paper

T315I+ tyrosine-kinase independent CML cells resistance News

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase Research Paper

Exosomes in diagnosis and therapy of prostate cancer Review

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma Review

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells Research Paper

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum Priority Research Paper

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients Research Paper

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer Review

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy Research Paper

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells Priority Research Paper

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma Research Paper

T315I⁺ tyrosine-kinase independent CML cells resistance News